European Pediatric Catheter Ablation Registry (EUROPA)
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 11, 2012 | ||||
| Last Updated Date | September 24, 2012 | ||||
| Start Date ICMJE | July 2012 | ||||
| Estimated Primary Completion Date | July 2016 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
To collect data on ablation procedures in the European pediatric population. [ Time Frame: After 12 months from the ablation procedure ] [ Designated as safety issue: Yes ] Primary outcome will be a combination of efficacy (arrhythmia recurrency) and safety (procedural and late complications) |
||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01691573 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
To describe and compare different ablation methodologies [ Time Frame: After 12 months from the ablation procedure ] [ Designated as safety issue: No ] Rate of index arrhythmia recurrence and rate of complications will be compared for different ablation technology (electroanatomical mapping system vs standard mapping) and for different energy source(radiofrequency vs cryo) |
||||
| Original Secondary Outcome Measures ICMJE |
To describe and compare different ablation methodologies [ Time Frame: After 12 months from the ablation procedure ] [ Designated as safety issue: No ] We seek to evaluate if rate of primary outcome differs by ablation methodology and/or energy source |
||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | European Pediatric Catheter Ablation Registry | ||||
| Official Title ICMJE | European Pediatric Catheter Ablation Registry | ||||
| Brief Summary | The main objective of the European Pediatric Catheter Ablation Registry is to collect data on ablation procedures in the European pediatric population in order to improve the management of this subset of patients. |
||||
| Detailed Description | Catheter ablation has revolutionized the management of cardiac arrhythmias in patients and has become first-line therapy for managing many pediatric patients with atrioventricular accessory pathway or atrioventricular nodal-mediated supraventricular tachycardia. Cardiac ablation in children is not a standardized procedure as in adults as evidence gaps still have to be filled. On a European perspective, lack of a dedicated scientific society has limited so far the collection and sharing of data among the most experienced centers. Actually there are no sufficient data available about the management of pediatric patients undergoing ablation in clinical practice, in particular regarding indications, methodology and clinical follow-up. |
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Probability Sample | ||||
| Study Population | European pediatric population |
||||
| Condition ICMJE | Cardiac Arrhythmias | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | Not Provided | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Enrollment ICMJE | Not Provided | ||||
| Estimated Completion Date | July 2016 | ||||
| Estimated Primary Completion Date | July 2016 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | up to 18 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Czech Republic, Germany, Italy, Netherlands | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01691573 | ||||
| Other Study ID Numbers ICMJE | EU01 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Paolo De Filippo, Ospedali Riuniti di Bergamo | ||||
| Study Sponsor ICMJE | Ospedali Riuniti di Bergamo | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Ospedali Riuniti di Bergamo | ||||
| Verification Date | September 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||